~~<i id='5A2E8D9013'><strike id='5A2E8D9013'><tt id='5A2E8D9013'><pre id='5A2E8D9013'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：comprehensive 2025-09-29 20:52:35 - browse：281

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Wikipedia

entertainment

focus

leisure time

focus

HeadspaceXR,developedwithfundingfromMeta,guidesusersthroughmeditationandotheractivities,suchasaTaiCh

WSS

Headspace, Meta partner to launch VR meditation app for Quest

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

How to bring more disabled researchers into academia

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Adults seen as increasingly susceptible to measles

New safety details link Apellis eye drug to rare cases of blindness

entertainment

explore

Wikipedia

Medicare details structure of new drug price negotiation program

How to bring more disabled researchers into academia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Activists slam private health insurers over coverage restrictions

UnitedHealth quietly bought dozens of outpatient centers

Continuity nursing helped my family in our darkest PICU moments

How to bring more disabled researchers into academia

Malaria cases in Florida and Texas: Here’s what you need to know

First medicine developed to treat MASH expected to be approved soon

entertainment

What the airline industry can learn from medicine

In his State of the Union, Biden takes clear aim at 'Big Pharma'

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The problem with charging patients to message their doctors

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

focus

leisure time

focus

focus